comprehensive -WSS

comprehensive

author：hotspot 2025-09-27 12:48:10 - browse：39

The Food and Drug Administration on Tuesday approved brexanolone, the first drug specifically targeted to treat postpartum depression — the most common complication of childbirth. Yet it’s a condition that often goes untreated because new mothers fear being stigmatized if they report symptoms.

Brexanolone is the first drug developed by and approved from Sage Therapeutics. The Cambridge, Mass.-based biotech company will market the new medicine under the brand name Zulresso.

“This approval is important for postpartum depression patients and it’s important for our company. It’s rare in your career when you can introduce a new medicine that is different from what’s out there,” said Sage CEO Jeff Jonas.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： New air purifier tech could be key to improving indoor air quality
Next article： Flagship, Pfizer team up in deal worth up to $7 billion

WSS

Pharma companies must ensure equitable access to obesity drugs

Stephen Quake on the Chan Zuckerberg quest to conquer disease

Vivek Ramaswamy, who's embraced Trump on the campaign trail, condemned him after Jan. 6

'Essentially witchcraft:' A former naturopath takes on the field

Phoenix breaks record with 19 consecutive days above 110 degrees Fahrenheit

A Theranos scientist

leisure time

comprehensive

focus

In age of alternative facts, a scholarly course on calling out crap

Johnson & Johnson sues to stop Medicare negotiation

Continuity nursing helped my family in our darkest PICU moments

Vivek Ramaswamy, who's embraced Trump on the campaign trail, condemned him after Jan. 6

Over 800 arrested across France in 3rd night of riots after fatal police shooting of teen

Readers discuss the intersection of pregnancy and addiction

Supreme Court strikes down use of affirmative action

Vivek Ramaswamy, who's embraced Trump on the campaign trail, condemned him after Jan. 6

In age of alternative facts, a scholarly course on calling out crap

Readers discuss the intersection of pregnancy and addiction

hotspot

Moderna says combo Covid

Cancer thrives by mutating. But sometimes, a mutation leaves it vulnerable

Medical device trials still don't enroll enough women, study finds

My daughter's legacy lives on through her writing, phage therapy

Moderna says combo Covid

House passes resolution saying Israel isn't a 'racist or apartheid state'

hotspot

leisure time

focus

focus